Last reviewed · How we verify

NCT03312959

Heavy Bupivacaine in Peribulbar Block

Status unknown Phase 4 Last updated 18 October 2017
What this trial tests

Phase 4 trial testing hyperbaric bupvacaine in Peribulbar block in Anesthetics, Local in 50 participants. Status unknown.

Timeline
1 November 2017
Primary endpoint
20 January 2018
31 January 2018

Quick facts

Lead sponsorCairo University
PhasePhase 4
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposehealth services research
Enrollment50
Start date1 November 2017
Primary completion20 January 2018
Estimated completion31 January 2018
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 30 to 80, any sex, with Anesthetics, Local. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Most of the ophthalmic procedures are performed under local anesthesia as the patient is often elderly and with diseases. This may increase the risk of morbidity and mortality under general anesthesia. Different eye blocks have been practiced with great success. Moreover, it is associated with less hemodynamic instability, less respiratory depression, better postoperative pain relief, and less nausea and vomiting than general anesthesia. It is also associated with a reduction in stress response, maintained oxygen saturation and cardiovascular stability, in addition to the production of good akinesia and anesthesia alleviating occulo-medullary reflexes, all make local anesthesia more superior and safe technique.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03312959.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing